Chronic Myelomonocytic Leukemia

Showing 51 - 75 of 159

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in United States (E7820)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Miami, Florida
  • +6 more
Apr 25, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Australia (Azacitidine, CC-486)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Newcastle, New South Wales, Australia
  • +10 more
Mar 29, 2022

Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Baltimore, Maryland
  • +2 more
Feb 25, 2022

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

Active, not recruiting
  • Anemia
  • +3 more
  • Epoetin Alfa
  • +2 more
  • Birmingham, Alabama
  • +512 more
Mar 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Severe/Moderate Coronavirus, Chronic Myelomonocytic Leukemia, MDS Trial in Villejuif (Blood samples)

Not yet recruiting
  • Severe/Moderate Coronavirus
  • +3 more
  • Blood samples
  • Villejuif, France
    Gustave Roussy Institut
Dec 20, 2021

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Birmingham (NTX-301)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 6, 2021

Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in

Completed
  • Relapsed or Refractory Haematological Malignancies Including
  • +10 more
  • Aachen, Germany
  • +11 more
Oct 21, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

MDS, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia Trial in Boston (Inqovi)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 29, 2021

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Denmark (Vitamin C, Placebo)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Vitamin C
  • Placebo
  • Aalborg, Denmark
  • +5 more
Sep 27, 2021

Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

Completed
  • Non-Hodgkin's Lymphoma
  • +7 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021

Registry on Hypomethylating Agents in Myeloid Neoplasms

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +2 more
  • non interventional
  • Feldkirch, Austria
  • +19 more
Jul 20, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Gilbert, Arizona
  • +12 more
Jun 15, 2021

Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,

Active, not recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Allogeneic Bone Marrow Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 13, 2021